Pharmaceutical Benefits Advisory Committee
Glossary of T Terms.
Glossary to accompany the November 1995 edition of the Guidelines for the Pharmaceutical Industry on Preparation of Submissions to the Pharmaceutical Benefits Advisory Committee
Glossary of Terms
Glossary of Terms to accompany the 1995 edition of the Guidelines for the Pharmaceutical Industry on Preparation of Submissions to the Pharmaceutical Benefits Advisory Committee
>> References
>> Glossary of terms - A
>> Glossary of terms - B
>> Glossary of terms - C
>> Glossary of terms - D
>> Glossary of terms - E
>> Glossary of terms - F
>> Glossary of terms - H
>> Glossary of terms - I & L
>> Glossary of terms - M
>> Glossary of terms - N
>> Glossary of terms - O
>> Glossary of terms - P
>> Glossary of terms - Q
>> Glossary of terms - R
>> Glossary of terms - S
>> Glossary of terms - T
>> Glossary of terms - U, V & W
Glossary of Terms to accompany the 1995 edition of the Guidelines for the Pharmaceutical Industry on Preparation of Submissions to the Pharmaceutical Benefits Advisory Committee
>> References
>> Glossary of terms - A
>> Glossary of terms - B
>> Glossary of terms - C
>> Glossary of terms - D
>> Glossary of terms - E
>> Glossary of terms - F
>> Glossary of terms - H
>> Glossary of terms - I & L
>> Glossary of terms - M
>> Glossary of terms - N
>> Glossary of terms - O
>> Glossary of terms - P
>> Glossary of terms - Q
>> Glossary of terms - R
>> Glossary of terms - S
>> Glossary of terms - T
>> Glossary of terms - U, V & W
- Technical efficiency The production of the greatest amount or quality of outcome for any specified level of resources.
- TGA Therapeutic Goods Administration
- Therapy The management and care of an individual for the purpose of combatting (eg preventing, curing, ameliorating) a disease or disorder; all resources provided in this management or care.
- Time preference The perceived advantage of receiving a benefit earlier and/or incurring a cost or harm later.
- Time-to-event data Data that incorporates a measure of the time lapse before an event occurs, eg time to relapse, time to death or time to treatment cessation.
- Toxicity (see also adverse outcome, adverse reaction, safety) The harm to health caused by a therapy (eg involving the proposed drug) considering the entire adverse reaction profile.
- Transferability (see external validity and transportability)
- Transportability (see also external validity)
A trial, study or model has transportability if it can produce unbiased inferences to another specified health care system (eg from overseas to Australia).
- Treatment effect (see also internal validity)
A difference in outcomes following provision of different therapies that remains after excluding random and systematic variation as alternative explanations.
- Trial (see also study)
An investigation of the health and/or economic impact of one or more therapies in humans which does involve a randomisation step.
